EU concludes talks on potential vaccine from BioNTech-Pfizer

SourceZawya
SectorEconomy
CountrySaudi Arabia

EU concludes talks on potential vaccine from BioNTech-Pfizer Envisaged contract would lead to an initial purchase of 200mln doses for all EU countries    BRUSSELS - The European Commission said on Wednesday it had concluded exploratory talks with BioNTech-Pfizer to purchase up to 300 million doses of a potential vaccine against COVID-19.The envisaged contract would lead to an initial purchase of 200 million doses for all EU countries, with an option to buy a further 100 million, the Commission said.(Reporting by Philip Blenkinsop and Marine Strauss) ((philip.blenkinsop@thomsonreuters.com; +32 2 585 2869; Reuters Messaging: philip.blenkinsop.thomsonreuters.com@reuters.net))Zawya CoveragebondsSaudi Electricity Company starts calling investors for green bonds offeringoil and gasUAE's ADNOC invests $245mln to upgrade main oil lines, Jebel Dhanna TerminalfintechUAE fund invests in Israeli fintech firm that offers loans to SMEs, freelancersbondsDubai-listed Tabreed ...read more...